Anika Therapeutics's total assets for Q4 2024 were $202.74M, a decrease of -12.39% from the previous quarter. ANIK total liabilities were $48.75M for the fiscal quarter, a -5.41% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.